Maher J - Search Results

1

Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells.

Maher J. Maher J. ISRN Oncol. 2012;2012:278093. doi: 10.5402/2012/278093. Epub 2012 Dec 9. ISRN Oncol. 2012. PMID: 23304553 Free PMC article.

2

Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells.

Davies DM, Maher J. Davies DM, et al. Among authors: maher j. Arch Immunol Ther Exp (Warsz). 2010 Jun;58(3):165-78. doi: 10.1007/s00005-010-0074-1. Epub 2010 Apr 6. Arch Immunol Ther Exp (Warsz). 2010. PMID: 20373147 Free article. Review.

3

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

Wilkie S, Burbridge SE, Chiapero-Stanke L, Pereira AC, Cleary S, van der Stegen SJ, Spicer JF, Davies DM, Maher J. Wilkie S, et al. Among authors: maher j. J Biol Chem. 2010 Aug 13;285(33):25538-44. doi: 10.1074/jbc.M110.127951. Epub 2010 Jun 18. J Biol Chem. 2010. PMID: 20562098 Free PMC article.

4

Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer.

van Schalkwyk MC, Papa SE, Jeannon JP, Guerrero Urbano T, Spicer JF, Maher J. van Schalkwyk MC, et al. Among authors: maher j. Hum Gene Ther Clin Dev. 2013 Sep;24(3):134-42. doi: 10.1089/humc.2013.144. Hum Gene Ther Clin Dev. 2013. PMID: 24099518 Clinical Trial.

5

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.

Alrifai D, Sarker D, Maher J. Alrifai D, et al. Among authors: maher j. Immunopharmacol Immunotoxicol. 2016;38(1):50-60. doi: 10.3109/08923973.2015.1100204. Epub 2015 Oct 16. Immunopharmacol Immunotoxicol. 2016. PMID: 26473647

6

CAR T-cell immunotherapy: The path from the by-road to the freeway?

Whilding LM, Maher J. Whilding LM, et al. Among authors: maher j. Mol Oncol. 2015 Dec;9(10):1994-2018. doi: 10.1016/j.molonc.2015.10.012. Epub 2015 Oct 23. Mol Oncol. 2015. PMID: 26563646 Free PMC article. Review.

7

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A, Costa-Guerra JA, Violette S, Itamochi H, Ghaem-Maghami S, Vallath S, Marshall JF, Maher J. Whilding LM, et al. Among authors: maher j. Mol Ther. 2017 Jan 4;25(1):259-273. doi: 10.1016/j.ymthe.2016.10.012. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129120 Free PMC article.

8

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

Emami-Shahri N, Foster J, Kashani R, Gazinska P, Cook C, Sosabowski J, Maher J, Papa S. Emami-Shahri N, et al. Among authors: maher j. Nat Commun. 2018 Mar 14;9(1):1081. doi: 10.1038/s41467-018-03524-1. Nat Commun. 2018. PMID: 29540684 Free PMC article.

9

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.

Kosti P, Maher J, Arnold JN. Kosti P, et al. Among authors: maher j. Front Immunol. 2018 May 22;9:1104. doi: 10.3389/fimmu.2018.01104. eCollection 2018. Front Immunol. 2018. PMID: 29872437 Free PMC article. Review.

10

Generation of hypoxia-sensing chimeric antigen receptor T cells.

Kosti P, Larios-Martinez KI, Maher J, Arnold JN. Kosti P, et al. Among authors: maher j. STAR Protoc. 2021 Aug 6;2(3):100723. doi: 10.1016/j.xpro.2021.100723. eCollection 2021 Sep 17. STAR Protoc. 2021. PMID: 34401788 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,268 results

Search Page

Filters